The two groups were compared in terms of patient characteristics, perioperative results, rates of surgical site infection, hematoma and wound dehiscence, times of returning to daily activities, complete healing time and overall patient satisfaction.Results: The median follow-up was 40.3 (38.7-44.7) months.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: We aimed to compare the efficacy of Bascom cleft lift (BCL) and crystallized phenol application in the treatment of sacrococcygealpilonidal sinus (SPS).Materials and Methods: This study included 83 SPS patients who were divided into two groups for treatment with either BCL (Group1: n=30) or crystallized phenol (Group 2: n=53).
📊
Key Findings & Data:The two groups were compared in terms of patient characteristics, perioperative results, rates of surgical site infection, hematoma and wound dehiscence, times of returning to daily activities, complete healing time and overall patient satisfaction.Results: The median follow-up was 40.3 (38.7-44.7) months.
💡
Conclusion & Impact:The length of hospital stay was longer in the BCL group than in thecrystallized phenol group (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Aim: We aimed to compare the efficacy of Bascom cleft lift (BCL) and crystallized phenol application in the treatment of sacrococcygealpilonidal sinus (SPS).Materials and Methods: This study included 83 SPS patients who were divided into two groups for treatment with either BCL (Group1: n=30) or crystallized phenol (Group 2: n=53). The two groups were compared in terms of patient characteristics, perioperative results, rates of surgical site infection, hematoma and wound dehiscence, times of returning to daily activities, complete healing time and overall patient satisfaction.Results: The median follow-up was 40.3 (38.7-44.7) months. The length of hospital stay was longer in the BCL group than in thecrystallized phenol group (P
🔖
Cite This Article
Aziret, M., Yirgin, H. (2022). Comparing the effects of bascom’s cleft lift andcrystallized phenol treatment on Type III-V Pilonidal Sinus Disease. Annals of Medical Research, Cilt: 28 - Sayı: 5, 863–869. https://ajindex.com/articles/445856
Thompson MR, Senapati A, Kitchen P. Simple day- case surgery for pilonidal sinus disease. Br J Surg 2011;98:198-209
Al-Khayat H, Al-Khayat H, Sadeq A, et al. A. Risk factors for wound complications in pilonidal sinus procedures. J Am Coll Surg 2007;205:439-44
Bali I, Aziret M, Sozen S, et al. Effectiveness of Limberg and Karydakis flap in recurrent pilonidal sinus disease. Clinics (Sao Paulo) 2015;70:350-5
Popeskou S, Christoforidis D, Ruffieux C, et al. Wound infection after excision and primary midline closure for pilonidal disease: risk factor analysis to improve patient selection. World J Surg 2011;35:206-11
Sozen S, Aziret M, Bali B, et al. Comparison of Drainage, Delayed Pits Excision, and Closure With Excision and Secondary Healing in Pilonidal Sinus Abscess Cases. Int Surg 2016;101:227-32
Al-Khamis A, McCallum I, King PM, et al. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev 2010;1:CD006213
Hull TL, Wu J. Pilonidal disease. Surg Clin North Am 2002;82:1169-85. 8. da Silva JH. Pilonidal cyst: cause and treatment. Dis Colon Rectum 2000;43:1146-56
Ertan T, Koc M, Gocmen E, et al. Does technique alter quality of life after pilonidal sinus surgery? Am J Surg 2005;190:388-92
Maurice BA, Greenwood RK. A conservative treatment of pilonidal sinus. Br J Surg 1964;51:510-2
Dag A, Colak T, Turkmenoglu O. Phenol procedure for pilonidal sinus disease and risk factors for treatment failure. Surgery 2012;151:113-7
Tezel E. A new classification according to navicular area concept for sacrococcygeal pilonidal disease. Colorectal Dis 2007;9:575-6
Irkorucu O. Management for pilonidal disease: Before you compare, use a classification system. Asian J Surg 2016;39:260-1
Nordon IM, Senapati A, Cripps NP. A prospective randomized controlled trial of simple Bascom’s technique versus Bascom’s cleft closure for the treatment of chronic pilonidal disease. Am J Surg 2009;197:189-92
Kaymakcioglu N, Yagci G, Simsek A, et al. Treatment of pilonidal sinus by phenol application and factors affecting the recurrence. Tech Coloproctol 2005;9:21-4
Kayaalp C, Aydin C. Review of phenol treatment in sacrococcygeal pilonidal disease. Tech Coloproctol 2009;13:189-93
Segre D, Pozzo M, Perinotti R, et al. The treatment of pilonidal disease: guidelines of the Italian Society of Colorectal Surgery (SICCR) Tech Coloproctol 2015;19:607-13